Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium - Reasons for cautious optimism

被引：59

作者：

Melo, LG

Pachori, AS

Kong, D

Gnecchi, M

Wang, K

Pratt, RE

Dzau, VJ

机构：

[1] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada

[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

来源：

CIRCULATION | 2004年 / 109卷 / 20期

关键词：

D O I：

10.1161/01.CIR.0000128597.37025.00

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2386 / 2393

页数：8

共 72 条

[21] Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts [J].

Klug, MG ;

Soonpaa, MH ;

Koh, GY ;

Field, LJ .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :216-224

[22] Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function [J].

Kocher, AA ;

Schuster, MD ;

Szabolcs, MJ ;

Takuma, S ;

Burkhoff, D ;

Wang, J ;

Homma, S ;

Edwards, NM ;

Itescu, S .

NATURE MEDICINE, 2001, 7 (04) :430-436

[23] Gene transfer for angiogenesis in coronary artery disease [J].

Laham, RJ ;

Simons, M ;

Sellke, F .

ANNUAL REVIEW OF MEDICINE, 2001, 52 :485-+

[24]

Leor J, 1996, CIRCULATION, V94, P332

[25] Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development [J].

Li, FQ ;

Wang, XJ ;

Capasso, JM ;

Gerdes, AM .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (08) :1737-1746

[26] Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia [J].

Losordo, DW ;

Vale, PR ;

Hendel, RC ;

Milliken, CE ;

Fortuin, FD ;

Cummings, N ;

Schatz, RA ;

Asahara, T ;

Isner, JM ;

Kuntz, RE .

CIRCULATION, 2002, 105 (17) :2012-2018

[27] Gene therapy for myocardial angiogenesis -: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia [J].

Losordo, DW ;

Vale, PR ;

Symes, JF ;

Dunnington, CH ;

Esakof, DD ;

Maysky, M ;

Ashare, AB ;

Lathi, K ;

Isner, JM .

CIRCULATION, 1998, 98 (25) :2800-2804

[28] Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart [J].

Mack, CA ;

Patel, SR ;

Schwarz, EA ;

Zanzonico, P ;

Hahn, RT ;

Ilercil, A ;

Devereux, RB ;

Goldsmith, SJ ;

Christian, TF ;

Sanborn, TA ;

Kovesdi, I ;

Hackett, N ;

Isom, OW ;

Crystal, RG ;

Rosengart, TK .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (01) :168-176

[29] Cardiomyocytes can be generated from marrow stromal cells in vitro [J].

Makino, S ;

Fukuda, K ;

Miyoshi, S ;

Konishi, F ;

Kodama, H ;

Pan, J ;

Sano, M ;

Takahashi, T ;

Hori, S ;

Abe, H ;

Hata, J ;

Umezawa, A ;

Ogawa, S .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) :697-705

[30] Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial [J].

Mann, MJ ;

Whittemore, AD ;

Donaldson, MC ;

Belkin, M ;

Conte, MS ;

Polak, JF ;

Orav, EJ ;

Ehsan, A ;

Dell'Acqua, G ;

Dzau, VJ .

LANCET, 1999, 354 (9189) :1493-1498

← 1 2 3 4 5 6 7 8 →